| abstract |
The present invention addresses the problem of the provision of a pharmaceutical combination composition and combinations of drugs for the prevention and / or treatment of dyslipidemic conditions such as atherosclerosis, hypercholesterolemia, low HDL disease in the blood, in mammals including humans. A pharmaceutical composition for the prevention and / or treatment of dyslipidemia, etc., comprising (a) a compound represented by the general formula (1) (in the formula, each symbol is the same defined in the specification) or a salt of the same or a solvate thereof, and (b) a cholesterol absorption inhibitor. |